The DOI matches its Crossref record; 515 of the 515 references it cites were found in a registry or an index.
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Abstract
The neurohypophysial hormone arginine vasopressin (AVP) is essential for a wide range of physiological functions, including water reabsorption, cardiovascular homeostasis, hormone secretion, and social behavior. These and other actions of AVP are mediated by at least three distinct receptor subtypes: V1a, V1b, and V2. Although the antidiuretic action of AVP and V2 receptor in renal distal tubules and collecting ducts is relatively well understood, recent years have seen an increasing understanding of the physiological roles of V1a and V1b receptors. The V1a receptor is originally found in the vascular smooth muscle and the V1b receptor in the anterior pituitary. Deletion of V1a or V1b receptor genes in mice revealed that the contributions of these receptors extend far beyond cardiovascular or hormone-secreting functions. Together with extensively developed pharmacological tools, genetically altered rodent models have advanced the understanding of a variety of AVP systems. Our report reviews the findings in this important field by covering a wide range of research, from the molecular physiology of V1a and V1b receptors to studies on whole animals, including gene knockout/knockdown studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 515
Israel, S., Lerer, E., Shalev, I., Uzefovsky, F., Reibold, M., Bachner‐Melman, R., Granot, R., Bornstein, G., KNAFO, A., Yirmiya, N., et al. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00434-2 · Cited by 122
The vasopressin Avpr1b receptor: Molecular and pharmacological studies
Roper, J. A., O'Carroll, A.-M., Young, W. S., & Lolait, S. (2010) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 122
Tilbrook, A. J., & Clarke, I. J. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.06.002 · Cited by 119
Briggs, F. N., & Munson, P. L. (1955) · Endocrinology · doi:10.1210/endo-57-2-205 · Cited by 119
Anxious–Retarded Depression: Relation with Plasma Vasopressin and Cortisol
de Winter, R. F. P., van Hemert, A. M., DeRijk, R. H., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., & Goekoop, J. G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300002 · Cited by 119
A Novel Type of Vasopressin Receptor on Anterior Pituitary Corticotrophs?*
Baertschi, A. J., & Friedli, M. (1985) · Endocrinology · doi:10.1210/endo-116-2-499 · Cited by 117
Keck, M. E., Kern, N., Erhardt, A., Unschuld, P. G., Ising, M., Salyakina, D., Müller, M. B., Knorr, C. C., Lieb, R., Hohoff, C., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30750 · Cited by 117
Therapeutic Potential of Vasopressin Receptor Antagonists
Ali, F., Guglin, M. E., Vaitkevicius, P. V., & Ghali, J. K. (2007) · Drugs · doi:10.2165/00003495-200767060-00002 · Cited by 116
Hirsch, A. T., Dzau, V. J., Majzoub, J. A., & Creager, M. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114182 · Cited by 116
Gal, C. S., Wagnon, J., Valette, G., Garcia, G., Pascal, M., Maffrand, J., & Fur, G. L. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39017-4 · Cited by 115
Perraudin, V., Delarue, C., Lefèbvre, H., Contesse, V., Kuhn, J., & Vaudry, H. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.7684742 · Cited by 115
Receptor activity‐independent recruitment of βarrestin2 reveals specific signalling modes
Terrillon, S., & Bouvier, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600387 · Cited by 115
THE EFFECT OF VASOPRESSIN INFUSION ON GLUCOSE METABOLISM IN MAN
SPRUCE, B. A., MCCULLOCH, A. J., BURD, J., ØRSKOV, H., HEATON, A., BAYLIS, P. H., & ALBERTI, K. G. M. M. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00145.x · Cited by 114 · cited 1×
“AVP administration into the NTS or cisterna magna induced hyperglycemia (347, 464, 542).”
BackgroundGlycogenolytic effect of vasopressin in the canine liver
Bergen, S. S., Sullivan, R. E., Hilton, J. G., Willis, S. W., & Itallie, T. B. V. (1960) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1960.199.1.136 · Cited by 114
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113
Self-citationOrally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior
Ferris, C. F., Lu, S., Messenger, T. L., Guillon, C. D., Heindel, N. D., Miller, M., KOPPEL, G. A., Bruns, F., & Simon, N. G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.001 · Cited by 113
LENG, G., ONAKA, T., CAQUINEAU, C., SABATIER, N., TOBIN, V, & TAKAYANAGI, Y. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00413-5 · Cited by 112
Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300562 · Cited by 112
Gal, C. S., Wagnon, J., Tonnerre, B., Roux, R., Garcia, G., Griebel, G., & Aulombard, A. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00035.x · Cited by 112
Shuaib, A. M., Wang, C. X., Yang, T., & Noor, R. (2002) · Stroke · doi:10.1161/01.str.0000039405.31526.06 · Cited by 111
West, D. V., Del‐Favero, J., Aulchenko, Y. S., Oswald, P., Souery, D., Forsgren, T., Sluijs, S., Belkacem, S., Adolfsson, R., Mendlewicz, J., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001420 · Cited by 110
Vasopressin in Circulatory Control and Hypertension
Johnston, C. I. (1985) · Journal of Hypertension · doi:10.1097/00004872-198512000-00001 · Cited by 109
Neurohypophyseal Hormone Receptors in the Rat Thymus, Spleen, and Lymphocytes
Elands, J., Resink, A., & de Kloet, E. R. (1990) · Endocrinology · doi:10.1210/endo-126-5-2703 · Cited by 109
Meynen, G., Unmehopa, U. A., van Heerikhuize, J. J., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.010 · Cited by 108
Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108
Overview of cellular electrophysiological actions of vasopressin
Raggenbass, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.074 · Cited by 107
Müller, M. B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A. E., Keck, M. E., Zimmermann, S., Holsboer, F., & Wurst, W. (2000) · Endocrinology · doi:10.1210/endo.141.11.7767 · Cited by 107
Gallo‐Payet, N., Pothier, P., & Isler, H. (1987) · Biochemistry and Cell Biology · doi:10.1139/o87-076 · Cited by 106
Oshikawa, S., Tanoue, A., Koshimizu, T.-A., Kitagawa, Y., & Tsujimoto, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.623 · Cited by 105
Self-citationDistribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron
Todd-Turla, K. M., Schnermann, J. B., Fejes‐Tóth, G., Náray‐Fejes‐Tóth, A., Smart, A., Killen, P. D., & Briggs, J. P. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.264.5.f781 · Cited by 105
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J., LUTON, J. P., Clauser, É., & BERTAGNA, X. Y. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118547 · Cited by 104
Lacroix, A., Tremblay, J., Touyz, R. M., Deng, L. Y., Larivière, R., Cusson, J. R., Schiffrin, E. L., & Hamet, P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4140 · Cited by 103
Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V1A receptor
Nakamura, Y., Haneda, T., Osaki, J., 宮田, 節., & Kikuchi, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00775-x · Cited by 102
Nephew, B. C., & Bridges, R. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.013 · Cited by 101
Chapter 14 Molecular pharmacology and modeling of vasopressin receptors
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39016-2 · Cited by 98
Effect of photoperiod on vasopressin-induced aggression in Syrian hamsters
Caldwell, H. K., & Albers, H. E. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.04.006 · Cited by 97
Hypermetabolism of Fat in V1a Vasopressin Receptor Knockout Mice
Hiroyama, M., Aoyagi, T., Fujiwara, Y., Birumachi, J., Shigematsu, Y., Kiwaki, K., Tasaki, R., Endo, F., & Tanoue, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0069 · Cited by 97
Self-citationHypothalamic Supraoptic and Paraventricular Nuclei
Armstrong, W. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-374245-2.00014-0 · Cited by 97
Raymond, V., Leung, P. C. K., Veilleux, R., & Labrie, F. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81183-2 · Cited by 96
Sodium Excretion in Response to Vasopressin and Selective Vasopressin Receptor Antagonists
Perucca, J., Bichet, D. G., Bardoux, P., Bouby, N., & Bankir, L. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010021 · Cited by 96
Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct
Schafer, J. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2002 · Cited by 95
AVP V selective antagonist SSR149415 blocks aggressive behaviors in hamsters
Blanchard, R. J., Griebel, G., Farrokhi, C. B., Markham, C. M., YANG, M., & Blanchard, D. C. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.024 · Cited by 95
Kirk, C. J., Rodrigues, L. M., & HEMS, D. A. (1979) · Biochemical Journal · doi:10.1042/bj1780493 · Cited by 94
Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats
Mlynarik, M., Zelena, D., Bagdy, G., Makara, G. B., & Ježová, D. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.12.007 · Cited by 94
Dempster, E. L., Burcescu, I., Wigg, K., Kiss, E., Baji, I., Gadoros, J., Tamás, Z., Kennedy, J. L., Vetró, A., Kovacs, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1189 · Cited by 93
Claudine, S.-L. G., Derick, S., Brossard, G., Maurice, M., Simiand, J., Rolf, G., Griebel, G., & Guillon, G. (2003) · Stress · doi:10.1080/1025389032000114524 · Cited by 92
Liu, J., Robinson, P. J., Funder, J. W., & Engler, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77278-5 · Cited by 91
Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways
Henderson, K. K., & Byron, K. L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00825.2006 · Cited by 90
Salomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0424-1 · Cited by 89
Dluzen, D. E., Muraoka, S., & Landgraf, R. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00691-0 · Cited by 89
Arginine Vasopressin Is Associated with Hypercortisolemia and Suicide Attempts in Depression
Inder, W. J., Donald, R. A., Prickett, T. C. R., FRAMPTON, C. M. A., Sullivan, P. F., Mulder, R., & Joyce, P. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00301-6 · Cited by 89
Zhou, Y., Leri, F., Cummins, E., Hoeschele, M., & Kreek, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301419 · Cited by 89
Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., & Owens, G. K. (1989) · Hypertension · doi:10.1161/01.hyp.14.4.413 · Cited by 89
Molecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87
Burnatowska-Hledin, M. A., & Spielman, W. S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113888 · Cited by 87
Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla
Grazzini, E., Lodboerer, A. M., Pérez‐Martin, A., BRESSION, D., & Guillon, G. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756565 · Cited by 87
Hermes, M. L. H. J., Ruijter, J. M., Klop, A., Buijs, R. M., & Renaud, L. P. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.2.705 · Cited by 87
Gutzler, S. J., Karom, M., Erwin, W. D., & Albers, H. E. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07190.x · Cited by 86 · cited 1×
“Conversely, aggression is increased by injection of the selective V1a/OT receptor antagonist into the AH in female Syrian hamsters (197).”
BackgroundSystematic Analysis of the Entire Second Extracellular Loop of the V1a Vasopressin Receptor
Conner, M. T., Hawtin, S. R., Simms, J., Wootten, D. L., Lawson, Z., Conner, A. C., Parslow, R. A., & Wheatley, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702151200 · Cited by 86
Griebel, G., Stemmelin, J., Gal, C. S., & Soubrié, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764797 · Cited by 86
Aoyagi, T., Izumi, Y., Hiroyama, M., Matsuzaki, T., Yasuoka, Y., Sanbe, A., Miyazaki, H., Fujiwara, Y., Nakayama, Y., Kohda, Y., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00088.2008 · Cited by 84
Self-citationInvolvement of vasopressin in affective disorders
Surget, A., & Belzung, C. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.065 · Cited by 84
Bataller, R. A., Nicolás, J., Ginès, P., Esteve, A., Görbig, M. N., García-Ramallo, E., Pinzani, M., Ros, J., Jiménez, W., Ap, T., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247484 · Cited by 83
Dunning, B. E., Moltz, J. H., & Fawcett, C. P. (1984) · Peptides · doi:10.1016/0196-9781(84)90109-8 · Cited by 83
Hodgson, R. A., Higgins, G. A., Guthrie, D. H., Lu, S. X., Pond, A. J., Mullins, D. E., Guzzi, M. F., Parker, E. M., & Varty, G. B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.021 · Cited by 83
Durroux, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.006 · Cited by 83
Vasopressin regulation of blood pressure and volume: findings from V1a receptor–deficient mice
Aoyagi, T., Koshimizu, T., & Tanoue, A. (2009) · Kidney International · doi:10.1038/ki.2009.319 · Cited by 83
Self-citationHORIBA, N., Suda, T., Aiba, M., Naruse, M., Nomura, K., Imamura, M., & Demura, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629226 · Cited by 81
Gavras, H., Hatzinikolaou, P., North, W. G., Bresnahan, M. R., & Gavras, I. (1982) · Hypertension · doi:10.1161/01.hyp.4.3.400 · Cited by 81
Waldhäusl, W. K., Bratusch-Marrain, P. R., Gasic, S., Korn, A., & Nowotny, P. (1982) · Diabetologia · doi:10.1007/bf00257722 · Cited by 80
Abu-Basha, E. A., Yibchok-anun, S., & Hsu, W. H. (2002) · Metabolism · doi:10.1053/meta.2002.34052 · Cited by 80
Robert, J., Clauser, É., Petit, P. X., & Ventura, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410655200 · Cited by 80
Plasma arginine vasopressin and motor activity in major depression
van Londen, L., KERKHOF, G. A., van den Berg, F., Goekoop, J. G., Zwinderman, A. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., & de Wied, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)80433-7 · Cited by 80
Vasopressin modulates liver regeneration in the Brattleboro rat
Russell, W. E., & Bucher, N. L. R. (1983) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1983.245.2.g321 · Cited by 80
Role of V1a vasopressin receptors in the control of aggression in Syrian hamsters
Elliott Albers, H., Dean, A., Karom, M. C., Smith, D., & Huhman, K. L. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.081 · Cited by 78
Johnson, A. E., Audigier, S., Rossi, F., Jard, S., Tribollet, E., & Barberis, C. (1993) · Brain Research · doi:10.1016/0006-8993(93)90795-o · Cited by 78
Molecular characterization of a cloned human oxytocin receptor
Kimura, T., Makino, Y., Saji, F., Takemura, M., Inoue, T., Kikuchi, T., Kubota, Y., Azuma, C., Nobunaga, T., Tokugawa, Y., et al. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310385 · Cited by 77
Schlosser, S. F., Almeida, O. F., Patchev, V. K., Yassouridis, A., & Elands, J. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956927 · Cited by 75
Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
Fujiwara, Y., Hiroyama, M., Sanbe, A., Aoyagi, T., Birumachi, J., Yamauchi, J., Tsujimoto, G., & Tanoue, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.136481 · Cited by 75
Self-citationInternalization, recycling, and redistribution of vasopressin receptors in rat hepatocytes.
Fishman, J. B., Dickey, B. F., Bucher, N. L. R., & Fine, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38919-6 · Cited by 75
Reflex effect of vasopressin after blockade of V1 receptors in the area postrema.
Hasser, E. M., & BISHOP, V. S. (1990) · Circulation Research · doi:10.1161/01.res.67.2.265 · Cited by 75
The vasopressin V1b receptor as a therapeutic target in stress-related disorders
Griebel, G., Simiand, J., Stemmelin, J., Gal, C., & Steinberg, R. (2003) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007033482850 · Cited by 74
Mechanisms of Action of CRF and Other Regulators of ACTH Release in Pituitary Corticotrophs
Abou‐Samra, A., Harwood, J. P., Catt, K. J., & Aguilera, G. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24951.x · Cited by 74
Altura, B. M. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30159-x · Cited by 73
Effect of AVP and oxytocin on insulin release: involvement of V1b receptors
Lee, B., Yang, C., Chen, T. H., Alazawi, N., & Hsu, W. H. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.6.e1095 · Cited by 73
Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct
Inoue, T. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00248-6 · Cited by 73
(2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00331-1 · Cited by 72
Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior
Bleickardt, C. J., Mullins, D. E., MacSweeney, C. P., Werner, B. J., Pond, A. J., Guzzi, M. F., Martin, F. D. C., Varty, G. B., & Hodgson, R. A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1354-x · Cited by 71 · cited 1×
“(56) reported that the V1a receptor antagonist JNJ-17308616 significantly reduced anxietylike behavior in five models of anxiety: rat elevated plusmaze, rat pup separation-induced ultrasonic vocalizations, mouse marble burying, rat elevated zero-maze, and rat conditioned lick suppression.”
BackgroundDonaldson, Z. R., Spiegel, L., & Young, L. J. (2010) · Behavioral Neuroscience · doi:10.1037/a0018094 · Cited by 71
G‐protein‐coupled receptor heteromers: function and ligand pharmacology
Franco, R., Casadó, V., Cortés, A., Mallol, J., Ciruela, F., Ferré, S., Lluı́s, C., & Canela, E. I. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707571 · Cited by 71
Acute esophageal variceal bleeding: Current strategies and new perspectives
Augustín, S. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i7.261 · Cited by 71
Dimerization Between Vasopressin V1b and Corticotropin Releasing Hormone Type 1 Receptors
Young, S. F., Griffante, C., & Aguilera, G. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9135-8 · Cited by 71
Area Postrema And Sympathetic Nervous System Effects Of Vasopressin And Angiotensin II
Hasser, E. M., Cunningham, J. T., Sullivan, M. J., et al. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03261.x · Cited by 70
Tsunematsu, T., Fu, L.-Y., Yamanaka, A., Ichiki, K., Tanoue, A., Sakurai, T., & van den Pol, A. N. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3490-07.2008 · Cited by 70
Self-citationFeifel, D., Melendez, G., & Shilling, P. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300378 · Cited by 70
V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze
Egashira, N., Tanoue, A., Higashihara, F., Mishima, K., Fukue, Y., Takano, Y., Tsujimoto, G., Iwasaki, K., & Fujiwara, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.050 · Cited by 69 · cited 2×
“In an examination of spatial learning, V1aR-KO mice, but not V1bR-KO mice, exhibited impairment in a radial arm maze (134).”
BackgroundMethodÅkerlund, M. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39030-7 · Cited by 69
Dinan, T. G., Lavelle, E., Scott, L. V., Newell-Price, J. D. C., Medbak, S., & Grossman, A. B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5723 · Cited by 69
Levin, R., Heresco-Levy, U., Bachner-Melman, R., Israel, S., Shalev, I., & Ebstein, R. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.014 · Cited by 68
Péqueux, C., Keegan, B. P., Hâgelstein, M.-T., Geenen, V. G., Legros, J.-J., & North, W. G. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00803 · Cited by 68
Robert, J., Auzan, C., Ventura, M. A., & Clauser, É. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510180200 · Cited by 67
Tribollet, E., Raufaste, D., Maffrand, J., & Gal, C. S. (1999) · Neuroendocrinology · doi:10.1159/000054409 · Cited by 66
Dimer-based model for heptaspanning membrane receptors
Franco, R., Casadó, V., Mallol, J., Ferré, S., Fuxé, K., Cortés, A., Ciruela, F., Lluís, C., & Canela, E. I. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.010 · Cited by 66
Perraudin, V., Delarue, C., de Keyzer, Y., BERTAGNA, X. Y., Kuhn, J., Contesse, V., Clauser, É., & Vaudry, H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673409 · Cited by 66
Moll, U. M., Lane, B., Robert, F., Geenen, V. G., & Legros, J. J. (1988) · Histochemistry and Cell Biology · doi:10.1007/bf00500641 · Cited by 66
Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia
Rofe, A. M., & Williamson, D. H. (1983) · Biochemical Journal · doi:10.1042/bj2120231 · Cited by 65
Arginine Vasopressin (AVP) and AVP-Like Immunoreactivity in Peripheral Tissues
Clements, J. A., & Funder, J. W. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-449 · Cited by 65
Berrada, K., Plesnicher, C. L., Luo, X., & Thibonnier, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002288200 · Cited by 65
Gaillard, R.-C., Schoenenberg, P., Favrod-Coune, C. A., Muller, A. F., Marie, J., Bockaert, J., & Jard, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2907 · Cited by 65
Chapter 4 Oxytocin: who needs it?
Insel, T. R., Gingrich, B., & Young, L. J. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)33005-4 · Cited by 64
Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets.
Gao, Z. Y., Drews, G., Nenquin, M., Plant, T. D., & Henquin, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55457-0 · Cited by 64
Regulation of Adrenocortical Function by Vasopressin
Gallo‐Payet, N., & Guillon, G. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978899 · Cited by 64
Feifel, D., Mexal, S., Melendez, G., Liu, P. Y. T., Goldenberg, J. R., & Shilling, P. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.15 · Cited by 64
Albizu, L., Teppaz, G., Seyer, R., Bazin, H., Ansanay, H., Manning, M., Mouillac, B., & Durroux, T. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061404q · Cited by 64
de la Cotte, N., Balestre, M., Aumelas, A., Mahé, E., Phalipou, S., Morin, D., Hibert, M., Manning, M., Durroux, T., Barberis, C., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01472.x · Cited by 63
Imai, Y., Nolan, P. L., & Johnston, C. I. (1983) · Circulation Research · doi:10.1161/01.res.53.2.140 · Cited by 63
Lemmens‐Gruber, R., & Kamyar, M.-R. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6054-2 · Cited by 63
Griffante, C., Green, A., Curcuruto, O., Haslam, C. P., Dickinson, B. A., & Arban, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706383 · Cited by 62
Brouard, R., Bossmar, T., Fournié‐Lloret, D., Chassard, D., & Åkerlund, M. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13302.x · Cited by 62
Physiology and pathophysiology of the vasopressinergic system
Vincent, J., & Su, F. (2008) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2008.03.004 · Cited by 61
Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice
Hiroyama, M., Wang, S., Aoyagi, T., Oikawa, R., Sanbe, A., Takeo, S., & Tanoue, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.010 · Cited by 61
Self-citationLink, H., Dayanithi, G., Föhr, K. J., & Gratzl, M. (1992) · Endocrinology · doi:10.1210/endo.130.4.1312449 · Cited by 61
Feifel, D., & Priebe, K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01100-3 · Cited by 61
Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro
Altemus, M. M., Cizza, G., & Gold, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)91326-a · Cited by 60
Hinson, J. P., Vinson, G. P., Porter, I. D., & Whitehouse, B. J. (1987) · Neuropeptides · doi:10.1016/0143-4179(87)90083-7 · Cited by 60
Vasopressin: A potent growth factor in adrenal glomerulosa cells in culture
Payet, N., Déziel, Y., & Lehoux, J.-G. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90252-8 · Cited by 60
Liedman, R., Hansson, S. R., Howe, D., Igidbashian, S., McLeod, A., Russell, R. J., & Åkerlund, M. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802306218 · Cited by 60
Actions of neurohypophysial peptides on pancreatic hormone release
Dunning, B. E., Moltz, J. H., & Fawcett, C. P. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.1.e108 · Cited by 60
Mikhailova, M. V., Mayeux, P. R., Jurkevich, A., Kuenzel, W. J., Madison, F. N., Periasamy, A., Chen, Y., & Cornett, L. E. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0160 · Cited by 59
Egashira, N., 三島, 健., Iwasaki, K., Oishi, R., & Fujiwara, M. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r14fm · Cited by 59
Self-citationOverstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 59
Evaluation of the Secretory Pattern of Plasma Arginine Vasopressin in Stroke Patients
BARRECA, T., Gandolfo, C., Corsini, G. P., Sette, M. D., Cataldi, A., Rolandi, E., & FRANCESCHINI, R. (2001) · Cerebrovascular Diseases · doi:10.1159/000047622 · Cited by 58
Zelena, D., Domokos, Á., Jain, S. K., Jankord, R., & Filaretova, L. P. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0096 · Cited by 58
Zhou, Y., Colombo, G., Carai, M. A. M., Ho, A., Gessa, G. L., & Kreek, M. J. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01532.x · Cited by 57
Arginine vasopressin V1a receptor antagonist impairs maternal memory in rats
Nephew, B. C., & Bridges, R. S. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.05.016 · Cited by 57
Hypothalamic Supraoptic and Paraventricular Nuclei
Armstrong, W. E. (2004) · Elsevier eBooks · doi:10.1016/b978-012547638-6/50016-x · Cited by 57
Martin, S. C., Yule, D. I., Dunne, M. J., Gallacher, D. V., & Petersen, O. H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08532.x · Cited by 56
Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions.
Guillon, G., Grazzini, E., Andrez, M., Breton, C., Trueba, M., Gal, C. S.-L., Boccara, G., Derick, S., Chouinard, L., & Gallo-payet, N. (1998) · Endocrine Research · doi:10.3109/07435809809032672 · Cited by 55
North, W. G., Fay, M. J., Longo, K. A., & Du, J. (1998) · PubMed · Cited by 55
Phencyclidine (PCP): A Dangerous Drug, but Useful in Schizophrenia Research
Murray, J. B. (2002) · The Journal of Psychology · doi:10.1080/00223980209604159 · Cited by 55
The role of vasopressin in acute cerebral vasospasm
Delgado, T., Arbab, M. A.-R., Warberg, J., et al. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.68.2.0266 · Cited by 55
Relation between human vasopressin 1a gene variance, fat intake, and diabetes
Enhörning, S., Leosdottir, M., Wallström, P., Gullberg, B., Berglund, G., Wirfält, E., & Melander, O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26382 · Cited by 55
Ghosh, P., Mikhailova, M., Bedolla, R. G., & Kreisberg, J. I. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.6.f972 · Cited by 55
Zelena, D., Mergl, Z., & Makara, G. B. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.034 · Cited by 54
Murat, B., Devost, D., Andrés, M., Mion, J., Boulay, V., Corbani, M., Zingg, H. H., & Guillon, G. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1202 · Cited by 54
Manaenko, A., Fathali, N., Khatibi, N. H., Lekic, T., Hasegawa, Y., Martin, R., Tang, J., & Zhang, J. H. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.018 · Cited by 54
Cottet, M., Albizu, L., Perkovska, S., Jean‐Alphonse, F., Rahmeh, R., Orcel, H., Méjean, C., Granier, S., Mendre, C., Mouillac, B., et al. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.10.003 · Cited by 54
Keegan, B. P., Akerman, B. L., Péqueux, C., & North, W. G. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9024-8 · Cited by 54
Vasopressin: Mechanisms of Receptor Activation
Jard, S. (1983) · Progress in brain research · doi:10.1016/s0079-6123(08)64405-2 · Cited by 53
Tahtaoui, C., Balestre, M., Klotz, P., Rognan, D., Barberis, C., Mouillac, B., & Hibert, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301128200 · Cited by 53
Vasopressin receptor 1a-mediated negative regulation of B cell receptor signaling
Hu, S.-B., Zhao, Z.-S., Yhap, C., Grinberg, A., Huang, S.-P., Westphal, H., & Gold, P. W. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00442-3 · Cited by 53
Zelena, D., Földes, A., Mergl, Z., Barna, I., Kovács, K., & Makara, G. B. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.04.007 · Cited by 53
Luminal vasopressin modulates transport in the rabbit cortical collecting duct.
Ando, Y., Tabei, K., & Asano, Y. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115398 · Cited by 52
Kirk, C. J., Verrinder, T. R., & Hems, D. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)81020-x · Cited by 52
Perraudin, V., Delarue, C., Lefèbvre, H., do Rego, J. L., Vaudry, H., & Kuhn, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1453 · Cited by 51
Taya, K., Gülşen, S., Okuno, K., Prieto, R., Marmarou, C. R., & Marmarou, A. (2008) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-85578-2_83 · Cited by 50
McEwen, B. B. (2004) · Advances in pharmacology · doi:10.1016/s1054-3589(04)50001-7 · Cited by 50
Hawthorn, J., Nussey, S. S., Henderson, J. R., & Jenkins, J. S. (1987) · Cell and Tissue Research · doi:10.1007/bf00214646 · Cited by 50
Transient Phosphorylation of the V1a Vasopressin Receptor
Innamorati, G., Hamid, M., & Birnbaumer, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7155 · Cited by 50
Stewart, L. Q., Roper, J. A., Young, W. S., O'Carroll, A.-M., & Lolait, S. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01704.x · Cited by 50
Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results
Brunner, J., Keck, M. E., Landgraf, R., Uhr, M., Namendorf, C., & Bronisch, T. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00071-8 · Cited by 49
Vasopressin Receptors in Human Adrenal Medulla and Pheochromocytoma
Grazzini, E., Breton, C., Derick, S., Andrés, M., Raufaste, D., Rickwaert, F., Boccara, G., Colson, P. H., Guérineau, N. C., Gal, C. S., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5775 · Cited by 49
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function
Locatelli, V., Bresciani, E., Tamiazzo, L., & Torsello, A. (2010) · Endocrine development · doi:10.1159/000262533 · Cited by 48
Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct
Carmosino, M., Brooks, H. L., Cai, Q., Davis, L. S., Opalenik, S. R., Hao, C., & Breyer, M. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00049.2006 · Cited by 48
Hausmann, H., Richters, A., Kreienkamp, H., Meyerhof, W., Mattes, H., Lederis, K. P., Zwiers, H., & Richter, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6907 · Cited by 48
Hawtin, S. R., Simms, J., Conner, M. T., Lawson, Z., Parslow, R. A., Trim, J. E., Sheppard, A., & Wheatley, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607639200 · Cited by 48
Egashira, N., Tanoue, A., Higashihara, F., Fuchigami, H., Sano, K., 三島, 健., Fukue, Y., Nagai, H., Takano, Y., Tsujimoto, G., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300784 · Cited by 48
Self-citationBiphasic forearm vascular responses to intraarterial arginine vasopressin.
Suzuki, S., Takeshita, A., Imaizumi, T., Hirooka, Y., Yoshida, M., Ando, S., & Nakamura, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114183 · Cited by 47
Foletta, V. C., Brown, F. D., & Young, W. S. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00448-5 · Cited by 47
Plasma Arginine Vasopressin in diabetic ketoacidosis
Walsh, C. H., Baylis, P. H., & Malins, J. M. (1979) · Diabetologia · doi:10.1007/bf01225456 · Cited by 47
Prevention of Preterm Delivery
Simhan, H. N., & Caritis, S. N. (2008) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000308285.45542.31 · Cited by 47
Li, X., Chan, T. O., Myers, V. D., Chowdhury, I., Zhang, X.-Q., Song, J., Zhang, J., Andrel, J. A., Funakoshi, H., Robbins, J. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.021352 · Cited by 47
Tashima, Y., Kohda, Y., Nonoguchi, H., Ikebe, M., Machida, K., Star, R. A., & Tomita, K. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100590 · Cited by 46
Self-citationMapping the Binding Site of Arginine Vasopressin to V 1a and V 1b Vasopressin Receptors
Rodrigo, J., Peña, A., Murat, B., Trueba, M., Durroux, T., Guillon, G., & Rognan, D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0202 · Cited by 46
Maeda, Y., Han, J., Gibson, C. C., & Knepper, M. A. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.1.f15 · Cited by 46
Murasawa, S., Matsubara, H., Kijima, K., Maruyama, K., Mori, Y., & Inada, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20042 · Cited by 45
Izumi, Y., Hori, K., Nakayama, Y., Kimura, M., Hasuike, Y., Nanami, M., Kohda, Y., Otaki, Y., Kuragano, T., Obinata, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050468 · Cited by 45
Self-citationAdrenal glomerulosa mitotic stimulation by posterior pituitary hormones
Payet, N., & Isler, H. (1976) · Cell and Tissue Research · doi:10.1007/bf00226051 · Cited by 44
Arrestin Effects on Internalization of Vasopressin Receptors
Bowen-Pidgeon, D., Innamorati, G., Hamid, M., & Birnbaumer, M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1395 · Cited by 44
Vasopressin Regulates Adrenal Functions by Acting through Different Vasopressin Receptor Subtypes
Grazzini, E., Boccara, G., BRESSION, D., Trueba, M., Durroux, T., Guillon, G., Gallo‐Payet, N., Chouinard, L. A., PAYET, M. D., & Gal, C. S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_41 · Cited by 43
Sistare, F. D., & Haynes, R. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38941-x · Cited by 43
Osmoregulation of Plasma Vasopressin in Diabetes Mellitus with Sustained Hyperglycemia
Iwasaki, Y., Kondo, K., Murase, T., et al. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.05124.x · Cited by 43
Homo‐ and Hetero‐Dimeric Complex Formations of the Human Oxytocin Receptor
Devost, D., & Zingg, H. H. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01188.x · Cited by 43
Chen, J., Young, S. F., Subburaju, S., Sheppard, J. R., Kiss, A., Atkinson, H. C., Wood, S. A., Lightman, S. L., Gal, C. S., & Aguilera, G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.037 · Cited by 43
Steinwall, M., Bossmar, T., Brouard, R., LAUDAŃSKI, T., Olofsson, P., Urban, R., Wolff, K., Lefur, G., & Åkerlund, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590400021144 · Cited by 43
Möhring, J., Kintz, J., Schoun, J., & McNeill, J. R. (1981) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198109000-00004 · Cited by 43
Lolait, S. J., Stewart, L. Q., Roper, J. A., Harrison, G., Jessop, D., Young, W. S., & O’Carroll, A. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01560.x · Cited by 43
Stewart, L. Q., Roper, J. A., Young, W. S., O’Carroll, A., & Lolait, S. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.009 · Cited by 42
Effects of Naloxone on Hypothalamo-Pituitary-Adrenocortical Activity in the Rat
Buckingham, J. C., & Cooper, T. A. (2008) · Neuroendocrinology · doi:10.1159/000124481 · Cited by 42
Hawtin, S. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511610200 · Cited by 42
Tanaka, K., Suzuki, M., Sumiyoshi, T., Murata, M., Tsunoda, M., & Kurachi, M. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.050 · Cited by 42
Trandafir, C., Nishihashi, T., Wang, A., et al. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03986.x · Cited by 42
Both V1A and V1B vasopressin receptors deficiency result in impaired glucose tolerance
Nakamura, K., Aoyagi, T., Hiroyama, M., Kusakawa, S., Mizutani, R., Sanbe, A., Yamauchi, J., Kamohara, M., Momose, K., & Tanoue, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.008 · Cited by 41
Self-citationDevost, D., & Zingg, H. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310461 · Cited by 41
Sato-Numata, K., Numata, T., Saito, T., Ueta, Y., & Okada, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001279 · Cited by 41
The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors
Caldwell, H. K., Stewart, J., Wiedholz, L. M., Millstein, R. A., Iacangelo, A. L., Holmes, A., Young, W. S., & Wersinger, S. R. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.001 · Cited by 40
Matsuoka, T., Sumiyoshi, T., Tanaka, K., Tsunoda, M., Uehara, T., Itoh, H., & Kurachi, M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.035 · Cited by 40
Acharjee, S., do Rego, J. L., Oh, D. Y., Ahn, R. S., Choe, H., Vaudry, H., Kim, K., Seong, J. Y., & Kwon, H. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408909200 · Cited by 40
Spiga, F., Harrison, L. R., Wood, S., Knight, D. M., MacSweeney, C. P., Thomson, F., Craighead, M., & Lightman, S. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0421 · Cited by 40
Shido, O., Kifune, A., & Nagasaka, T. (1984) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.34.397 · Cited by 39
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
“Upon its central release, VP can modulate the activation of many brain regions via binding to vasopressin receptors (discussed further in section 3.a.), thereby regulating social, emotional, and cognitive behaviors (Veenema & Neumann, 2008; Koshimizu et al., 2012; Albers, 2014).”
BackgroundIntranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
Parker, K. J., Oztan, O., Libove, R. A., Sumiyoshi, R. D., Jackson, L. P., Karhson, D. S., Summers, J. E., Hinman, K. E., Motonaga, K. S., Phillips, J. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705521114 · Cited by 349
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
Song, Z., & Albers, H. E. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.004 · Cited by 244
“Because OTRs, V1aRs, V1bRs, and V2Rs are found on peripheral tissues of virtually every major physiological system of the body, the impact of these peptides is likely to be very widespread [2; 20].”
Background
Metadata
- Authors
- Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2012-10
- Volume
- 92
- Issue
- 4
- Pages
- 1813-1864
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2129819610
- Cited by
- 407
- References
- 515
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.